Obesity predisposes patients to several debilitating metabolic diseases, cardiovascular disorders, liver diseases, and cancers. Research into the mechanisms underlying obesity and its comorbid conditions presents an opportunity to make a significant impact on human health.

Diet-Induced Obese (DIO) Mice in Metabolic Studies

Join Taconic Biosciences for this free webinar on the application of diet-induced obese animal models used for studying human obesity and its associated pathologies.

• Learn how to leverage DIO mice in metabolic disorder research.
  
  
• Discover applications for DIO mice in studying metabolically-driven liver diseases.
  
  
• Discuss protocols for robust study design with DIO mice.

Presenters:

Michael R. Briggs, PhD
CSO

Michael Briggs is the CSO of Woodland Biosciences. He has developed a deep interest in oncology medicine and is exploring discovery research into the connections between obesity, diabetes, liver disease, and fast-growing cancers such as hepatocellular carcinoma and pancreatic cancer.

Nikole Siegmund, BS, LAT
Director of Laboratory Operations

Nikole Siegmund is the director of laboratory operations at Woodland Biosciences and a former Team Leader for research at Charles River Laboratories. Her team represents decades of combined CRO and pharmaceutical company experience.

Watch Now!